Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Bruce J. Averbook"'
Publikováno v:
Surgical Oncology. 27:327-332
Background Though sentinel lymph node biopsy (SLNB) is standard of care for early breast cancer, concern remains for false negative nodes and potential implications for understaging and under-treatment, particularly when only one sentinel node is ret
Autor:
David H. Lawson, Emily Y. Chu, Clara Curiel-Lewandrowski, Mariah M. Johnson, Susan M. Swetter, Lee D. Cranmer, Anna Bar, William E. Carson, John M. Kirkwood, Ahmad A. Tarhini, Debbie Miller, John T. Vetto, Pamela B. Cassidy, Jennifer A. Stein, Kenneth F. Grossmann, Mirna Becevic, Lisa G. Aspinwall, Darrel L. Ellis, Robert P. Dellavalle, Michael W. Piepkorn, Vernon K. Sondak, David E. Fisher, Svetomir N. Markovic, Joanne M. Jeter, Suephy C. Chen, Michael K Wong, Caroline C. Kim, Brian Pollack, Frank L. Meyskens, Laura K. Ferris, June K. Robinson, Michael E. Ming, Philip D. Leming, Larisa J. Geskin, Bruce J. Averbook, Suraj S. Venna, Shannon C. Trotter, Oliver J. Wisco, Debjani Sahni, Aaron R. Mangold, Kari Kendra, Clara E. Stemwedel, Jason E. Hawkes, Rhoda M. Alani, Douglas Grossman, Tawnya L. Bowles, Arthur J. Sober, Sanjiv S. Agarwala, Sancy A. Leachman, Matthew H. Taylor, Mary C. Martini, William H. Sharfman, Kim Margolin, Alexander J. Stratigos, Kelly C. Nelson, Neil F. Box
Publikováno v:
Melanoma Management
Melanoma is usually apparent on the skin and readily detected by trained medical providers using a routine total body skin examination, yet this malignancy is responsible for the majority of skin cancer-related deaths. Currently, there is no national
Autor:
Sabino Zani, Nabil Wasif, Heidi Nelson, Mary Sue Brady, Karl Y. Bilimoria, Jacob B. Allred, Vera J. Suman, Mark B. Faries, Travis E. Grotz, James W. Jakub, Alicia M. Terando, Heather B. Neuman, Bruce J. Averbook, Charlotte E. Ariyan, Douglas S. Tyler, Jeffrey M. Farma, Amod A. Sarnaik, Jeffrey D. Wayne
Publikováno v:
Annals of Surgery. 265:192-196
Minimally invasive inguinal lymph node dissection (MILND) is a novel approach to inguinal lymphadenectomy. SAFE-MILND (NCT01500304) is a multicenter, phase I/II clinical trial evaluating the safety and feasibility of MILND for patients with melanoma
Autor:
Benjamin Zendejas, Amod A. Sarnaik, Mark B. Faries, Heather B. Neuman, Jeffrey M. Farma, Karl Y. Bilimoria, James W. Jakub, Mary Sue Brady, Charlotte E. Ariyan, Alicia M. Terando, Nabil Wasif, Sabino Zani, Douglas S. Tyler, Bruce J. Averbook, David R. Farley
Publikováno v:
Surgical Endoscopy. 31:3313-3319
Outcomes of surgical trials hinge on surgeon selection and their underlying expertise. Assessment of expertise is paramount. We investigated whether surgeons' performance measured by the fundamentals of laparoscopic surgery (FLS) assessment program c
Autor:
Clara Curiel-Lewandrowski, Alessandro Testori, John M. Kirkwood, Svetomir N. Markovic, Kenneth W. Gow, Vernon K. Sondak, Bruce J. Averbook, Phillip M. Ecker, Mark R. Pittelkow, Susan M. Swetter, Sandra J. Lee, Jane L. Messina, Ronald S. Go, Michael S. Sabel, Keith A. Delman, Sancy A. Leachman, Jonathan S. Zager, Drazen M. Jukic
Publikováno v:
Cancer. 119:4012-4019
BACKGROUND The management of pediatric melanoma (PM) has largely been extrapolated from adult data. However, the behavior of PM appears to differ from its adult counterparts. Therefore, an international PM registry was created and analyzed. METHODS T
Autor:
Jonathan S. Zager, Christopher A. Puleo, Anne M. Wallace, Julian A. Kim, Vernon K. Sondak, Schlomo Schneebaum, Dennis King, Lori Christman, Steve R. Martinez, Mark B. Faries, Jane L. Messina, Stanley P. L. Leong, Bruce J. Averbook
Publikováno v:
Annals of Surgical Oncology
Background [99mTc]Tilmanocept is a CD206 receptor-targeted radiopharmaceutical designed for sentinel lymph node (SLN) identification. Two nearly identical nonrandomized phase III trials compared [99mTc]tilmanocept to vital blue dye. Methods Patients
Autor:
Vera J. Suman, Amod A. Sarnaik, Mark B. Faries, Bruce J. Averbook, Alicia M. Terando, Jacob B. Allred, James W. Jakub, Benjamin Zendejas, Travis E. Grotz, Karl Y. Bilimoria, Heather B. Neuman, Jeffrey M. Farma, Douglas S. Tyler, Sabino Zani, Jeffrey D. Wayne, Nabil Wasif, Charlotte E. Ariyan
Background Minimally invasive inguinal lymphadenectomy (MILND) is a novel procedure with the potential to decrease surgical morbidity compared with the traditional open approach. The current study examined the feasibility of a combined didactic and h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be10ee4d461ea4c01cb290ff567fd0ab
https://europepmc.org/articles/PMC5012184/
https://europepmc.org/articles/PMC5012184/
Autor:
Seng-Jaw Soong, Richard Essner, Jeffrey E. Gershenwald, Merrick I. Ross, Stanley P. L. Leong, Harald J. Hoekstra, Eli Avisar, David Chu, Shouluan Ding, Eric D. Whitman, Mohammed Kashani-Sabet, Daniel L Debonis, Axel Hauschild, John T. Vetto, Gregory D. Ayers, Harold J. Wanebo, Mark B. Faries, Kim James Charney, Barbara A. Pockaj, Bruce J. Averbook, Yu Shyr, Michael P. Vezeridis, Richard L. White, Virginia H. Stell, Friederike Egberts, Vijay Trisal, Zhiguo Zhao, Carlos A. Garberoglio, Aaron H. Chevinsky, Lynne D. Berry, Jonathan C. Salo
Publikováno v:
Annals of Surgical Oncology, 18(13), 3593-3600. SPRINGER
Numerous predictive factors for cutaneous melanoma metastases to sentinel lymph nodes have been identified; however, few have been found to be reproducibly significant. This study investigated the significance of factors for predicting regional nodal
Autor:
Bruce J. Averbook
Publikováno v:
Journal of Clinical Oncology. 29:2137-2141
Autor:
Hiroshi Tanaka, Bruce J. Averbook, Suyu Shu, Peter A. Cohen, Takashi Hayashi, Rongfu Wang, Junta Tanaka
Publikováno v:
Clinical Immunology. 104:14-20
Dendritic cells (DCs) are potent antigen-presenting cells capable of inducing strong immune responses to weak tumor-associated antigens. Among various DC-based approaches, cancer immunotherapy with DC–tumor fusion hybrids offers advantages of polyc